Protein phosphatase 5 is a negative regulator of estrogen receptor-mediated transcription

Molecular Endocrinology

Volumn 18, Issue 5, 2004, Pages 1131-1143

  Ikeda, Kazuhiro ^a   Ogawa, Sumito ^b   Tsukui, Tohru ^a   Horie Inoue, Kuniko ^a   Ouchi, Yasuyoshi ^a   Kato, Shigeaki ^c   Muramatsu, Masami ^a   Inoue, Satoshi ^a,b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CYCLIN D1; EPIDERMAL GROWTH FACTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUTATHIONE TRANSFERASE; MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PHOSPHATASE 5; PROTEIN PS2; SERINE; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BINDING; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYBRID; IMMUNOPRECIPITATION; MODULATION; MUTANT; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SCREENING; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MUTATION; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN BINDING; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 2342573676     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0308     Document Type: Article

References (38)

1. Muramatsu M, Inoue S 2000 Estrogen receptors: how do they control reproductive and nonproductive functions? Biochem Biophys Res Commun 270:1-10
2. Shao D, Lazar MA 1999 Modulating nuclear receptor function: may the phos be with you. J Clin Invest 103: 1617-1618
3. Ali S, Metzger D, Bornert JM, Chambon P 1993 Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J 12:1153-1160
4. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
5. Tremblay A, Tremblay GB, Labrle F, Giguere V 1999 Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1. Mol Cell 3:513-519
6. Chen D, Pace PE, Coombes RC, Ali S 1999 Phosphorylation of human estrogen receptor α by protein kinase A regulates dimerization. Mol Cell Biol 19:1002-1015
7. Chen D, Riedl T, Washbrook E, Pace PE, Coombes RC, Egly JM, Ali S 2000 Activation of estrogen receptor a by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell 6:127-137
8. Le Goff P, Montano MM, Schodin DJ, Katzenellenbogen BS 1994 Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem 269:4458-4466
9. Joel PB, Traish AM, Lannigan DA 1998 Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem 273:13317-13323
10. Barford D, Das AK, Egloff MP 1998 The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 27:133-164
11. Cohen PT 1997 Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem Sci 22:245-251
12. Chen MX, McPartlin AE, Brown L, Chen YH, Barker HM, Cohen PT 1994 A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus. EMBO J 13: 4278-4290
13. Hirano T, Kinoshita N, Morikawa K, Yanagida M 1990 Snap helix with knob and hole: essential repeats in S. pombe nuclear protein nuc2+. Cell 60:319-328
14. Sikorski RS, Boguski MS, Goebl M, Hieter P 1990 A repeating amino acid motif in CDC23 defines a family of proteins and a new relationship among genes required for mitosis and RNA synthesis. Cell 60:307-317
15. Blatch GL, Lassie M 1999 The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. Bioessays 21:932-939
16. Chen MS, Silverstein AM, Pratt WB, Chinkers M 1996 The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant J Biol Chem 271:32315-32320
17. Morita K, Saitoh M, Tobiume K, Matsuura H, Enomoto S, Nishitoh H, Ichijo H 2001 Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J 20:6028-6036
18. Chinkers M 1994 Targeting of a distinctive protein-serine phosphatase to the protein kinase-like domain of the atrial natriuretic peptide receptor. Proc Natl Acad Sci USA 91:11075-11079
19. Ollendorff V, Donoghue DJ 1997 The serine/threonine phosphatase PP5 interacts with CDC16 and CDC27, two tetratricopeptide repeat-containing subunits of the anaphase-promoting complex. J Biol Chem 272:32011-32018
20. Lubert EJ, Hong Y, Sarge KD 2001 Interaction between protein phosphatase 5 and the A subunit of protein phosphatase 2A: evidence for a heterotrimeric form of protein phosphatase 5. J Biol Chem 276:38582-38587
21. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758
22. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937
23. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JA, Carlquist M 1999 Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full antagonist. EMBO J 18:4608-4618
24. Ogawa S, Inoue S, Orimo A, Hosoi T, Ouchi Y, Muramatsu M 1998 Cross-inhibition of both estrogen receptor α and β pathways by each dominant negative mutant. FEBS Lett 423:129-132
25. Brown AM, Jeltsch JM, Roberts M, Chambon P 1984 Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 81:6344-6348
26. Dubik D, Shiu RP 1992 Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7:1587-1594
27. Sabbah M, Courilleau D, Mester J, Redeuilh G 1999 Estrogen Induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci USA 96:11217-11222
28. Castro-Rivera E, Samudio I, Safe S 2001 Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J Biol Chem 276:30853-30861
29. Smith CL 1998 Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol Reprod 58:627-632
30. Lu Q, Surks HK, Ebling H, Baur WE, Brown D, Pallas DC, Karas RH 2003 Regulation of estrogen receptor α-mediated transcription by a direct interaction with protein phosphatase 2A. J Biol Chem 278:4639-4645
31. Sinclair C, Borchers C, Parker C, Tomer K, Charbonneau H, Rossie S 1999 The tetratricopeptide repeat domain and a C-terminal region control the activity of Ser/Thr protein phosphatase 5. J Biol Chem 274:23666-23672
32. Owens-Grillo JK, Hoffmann K, Hutchison KA, Yem AW, Deibel Jr MR, Handschumacher RE, Pratt WB 1995 The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J Biol Chem 270:20479-20484
33. Ratajczak T, Carrello A 1996 Cyclophilin 40 (CyP-40), mapping of its hsp90 binding domain and evidence that FKBP52 competes with CyP-40 for hsp90 binding. J Biol Chem 271:2961-2965
34. Urban G, Golden T, Aragon IV, Scammell JG, Dean NM, Honkanen RE 2001 Identification of an estrogen-inducible phosphatase (PP5) that converts MCF-7 human breast carcinoma cells into an estrogen-independent phenotype when expressed constitutively. J Biol Chem 276:27638-57646
35. Zuo Z, Urban G, Scammell JG, Dean NM, McLean TK, Aragon I, Honkanen RE 1999 Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. Biochemistry 38: 8849-8857
36. Zuo Z, Dean NM, Honkanen RE 1998 Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest. J Biol Chem 273:12250-12258
37. Niwa H, Yamamura K, Miyazaki J 1991 Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199
38. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I 1996 Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 93:1320-1324